| Preliminary list as of October 2011 |
| Speaker |
Country |
Topic |
| Stephanie |
Amiel |
UK |
DEBATE (with Eric Renard): SMBG (vs CGM) provides everything we need to manage diabetes well |
| Javier |
Ampudia-Blasco |
Spain |
Continuous glucose monitoring: reimbursement across Europe - Spain |
| Tadej |
Battelino |
Slovenia |
Continuous glucose monitoring: reimbursement across Europe - Slovenia |
| Carsten |
Benesch |
Germany |
Diabetes Technologies - Regulatory Topics that need more focus in Europe - The German experience |
| Richard M. |
Bergenstal |
USA |
Utilizing self-monitored blood glucose data to further characterize glycemic control in the ACCORD trial |
| Bruce |
Bode |
USA |
Close loop of both IV and SC insulin in the hospital |
| Bruce |
Bode |
USA |
Patch Pumps: current and what is in development |
| Jan |
Bolinder |
Sweden |
Continuous glucose monitoring: reimbursement across Europe - Sweden |
| Bruce |
Buckingham |
USA |
MMPC full closed loop control |
| Antonio |
Ceriello |
Spain |
Personalizing Treatment in Type 2 Diabetes: a SMBG inclusive innovative approach |
| Peter |
Chase |
USA |
Cost and safety of Insulin Pump Therapy in youth with T1D |
| Claudio |
Cobelli |
Italy |
The fundamentals of the artificial pancreas design |
| Thomas |
Danne |
Germany |
Predictive low-glucose suspend: an option for routine out-patients care? |
| Eyal |
Dassau |
USA |
Design control and clinical evaluation of an artificial pancreas utilizing ultra-fast insulin delivery methods |
| Alberto |
de Leiva |
Spain |
Ninety years of insulin replacement therapy in diabetic pregnancies: an overview |
| Hans |
de Vries |
the Netherlands |
Continuous glucose monitoring: reimbursement across Europe - the Netherlands |
| Peter |
Diem |
Switzerland |
Continuous glucose monitoring: reimbursement across Europe - Switzerland |
| Francis |
Doyle III |
USA |
System and control engineering for type 1 diabetes: the design of an artificial pancreas |
| Satish |
Garg |
USA |
Role of Type 2 drugs in managing type 1 diabetes |
| Satish |
Garg |
USA |
Non-Insulin therapies used for type 1 DM |
| Peter |
Gottlieb |
USA |
B-cell targeted therapies-immune-modulation |
| Philippe |
Halban |
Switzerland |
Can we multiply residual Beta cells in diabetes? |
| David M. |
Harlan |
USA |
Electronic communication tools to integrate diabetes care delivered by educators, primary care physicians, and specialists |
| Lutz |
Heinemann |
Germany |
Continuous glucose monitoring: reimbursement across Europe - Germany |
| Irl |
Hirsch |
USA |
Overview of SMBG, pump and sensor use and non-use in the T1D Exchange |
| Moshe |
Hod |
Israel |
Insulin analogues and pregnancy - the Levemir in pregnancy study |
| Roman |
Hovorka |
UK |
Diabetes Technologies - Regulatory Topics that need more focus in Europe - The British experience |
| Roman |
Hovorka |
UK |
AP@HOME: AP-algorithms: the Cambridge ‘model predictive control’ approach |
| Roman |
Hovorka |
UK |
Closed-loop systems for overnight control, challenges and the path forward |
| Neil |
Hutcher |
USA |
Assuring the delivery of safe, effective and efficient bariatric surgery throughout the world |
| Lois |
Jovanovic |
USA |
Continuous glucose monitoring in women with type 1 diabetes during pregnancy trial – CONCEPTT |
| Neal |
Kaufman |
USA |
How to create the policy context to increase reimbursement for technology enabled self-management support interventions for patients with diabetes |
| Neal |
Kaufman |
USA |
What are the evidence-based principles that lead to successful technology-enabled diabetes self-management support interventions |
| Giordani |
Lanzola |
Italy |
AP@home: How to move from CRC to home: platform and telemedicine requirements |
| Yoeri M. |
Luijf |
the Netherlands |
Diabetes Technologies - Regulatory Topics that need more focus in Europe - The Dutch experience |
| Lalo |
Magni |
Italy |
AP @Home: AP-algorithms: model predictive control with a feedback/feedforward meal compensation |
| John |
Pender |
USA |
Type 2 Diabetes Mellitus: identification and correction of the metabolic error through bariatric surgery |
| Moshe |
Phillip |
Israel |
Continuous glucose monitoring: reimbursement across Europe - Israel |
| John |
Pickup |
UK |
What next for diabetes technology: strategic directions for the next ten years |
| John |
Pickup |
UK |
Continuous glucose monitoring: reimbursement across Europe - UK |
| Almino |
Ramos |
Brazil |
Innovations in surgical approaches and devices metabolic surgery |
| Werner |
Regittnig |
Austria |
AP&HOME: Development of single-port AP systems |
| Eric |
Renard |
France |
AP @HOME: Preliminary results from the CAT trial, a comparison of AP-algorithms vs. open-loop insulin pump management |
| Eric |
Renard |
France |
DEBATE (With Stephanie Amiel): SMBG (vs CGM) provided everything you need to manage diabetes well |
| Eric |
Renard |
France |
Continuous glucose monitoring: reimbursement across Europe - France |
| Franck |
Robin |
Switzerland |
AP @HOME: Development of single-port AP systems |
| Andrea |
Scaramuzza |
Italy |
Fine tuning of insulin pump therapy in children with type 1 diabetes: the importance of bolus timing and type |
| Jay |
Skyler |
USA |
Beta cell replacement with stem cells – becoming a reality |
| Jay |
Skyler |
USA |
Multi-hormonal control of glucose metabolism in Type 1 diabetes |
| Steven |
Willi |
USA |
Comparison of severe hypoglycemia and DKA in T1D Exchange participants using pumps versus injections with and without sensors |
| Yariv |
Yogev |
Israel |
GDM-Obesity and metabolic syndrome in pregnancy |
| Howard |
Zisser |
USA |
Diabetes Technologies - Regulatory Topics that need more focus in Europe - The U.S. view |
| Howard |
Zisser |
USA |
Clinical hurdles and possible solutions in the implementation of close-loop control in T1DM |